Elbasvir/Grazoprevir (Zepatier™) Drug Interaction Guide
Update: 24 November, 2023
Elbasvir/grazoprevir (Zepatier™) is a hepatitis C virus (HCV) medication used to treat chronic hepatitis C. The medication works by inhibiting viral replication. Elbasvir and grazoprevir are substrates of CYP3A4 and P-glycoprotein (P-gp). Coadministration with moderate or strong CYP3A4 inhibitors or inducers is likely to result in interactions. Grazoprevir is a substrate of OATP1B1/3 transporters. Coadministration with medications that inhibit OATP1B1/3 should be avoided.
File format: PDF
Size: 86 KB
MD5 Checksum: 69FD5E72F28792A61F61BCB2332F5841
Publication date: 24 November, 2023
Downloads: -
PDF Link: Elbasvir/Grazoprevir (Zepatier™) Drug Interaction Guide PDF